期刊文献+

收缩性心力衰竭和舒张性心力衰竭患者血浆N末端B型利钠肽原的对比分析及与年龄的关系 被引量:3

Plasma level of N-terminal pro-brain natiuretic peptide in systolic vs diastolic heart failure and its relationship with age
下载PDF
导出
摘要 目的 探讨收缩性心力衰竭(HF)和舒张性HF患者血浆N末端B型利钠肽原(NT-proBNP)的差异及与年龄的关系。方法 收入2010年1月至2011年10月在山西省晋城市人民医院心内科住院的202例心力衰竭患者,其中收缩性HF 104例,舒张性HF 98例,所有患者均具有HF的症状、体征并行超声心动图检查。202例患者初次入院后判断纽约心脏病协会(NYHA)心功能分级,行超声心动图检查,入院后初始测定血浆NT-proBNP,比较其在收缩性与舒张性HF中的差别,并比较不同心功能组、不同年龄组血浆NT-proBNP的差异,并设20例健康人作为对照组。结果 收缩性HF、舒张性HF组血浆NT-proBNP均较正常对照组明显升高(P<0.01),收缩性HF组血浆NT-proBNP显著高于舒张性HF组(P<0.05)。在任何年龄组,随着NYHA心功能分级的增高,NT-proBNP浓度升高(P<0.05)。随着年龄增长,NT-proBNP浓度呈现上升趋势,但差异未达统计学意义(P>0.05)。结论 收缩性HF患者血浆NT-proBNP水平高于舒张性HF患者,HF患者血浆NT-proBNP与NYHA心功能分级密切相关。NT-proBNP浓度与年龄无显著相关性。 Objective To determine the plasma level of N-terminal pro-brain natriuretic peptide(NT-proBNP) between patients with systolic or diastolic heart failure (HF) and the relationship with age. Methods A total of 202 patients diagnosed with HF (104 cases with systolic HF, and 98 cases with diastolic HF) admitted in our department from January 2010 to October 2011 were enrolled in this study. They all presented the signs and symptoms of HF, and identified with echocardiography. These patients were divided into Ⅱ to Ⅳ class according to New York Heart Association Functional Classification (NYHA), plasma level of NT-proBNP was measured in the systolic and diastolic HF groups on admission, and the results were compared among different HF groups and age groups. Twenty sex- and age-matched healthy individuals served as normal control. Results The median NT-proBNP level was significantly higher in systolic HF and diastolic HF group than in healthy control (P〈0.01), and that of systolic HF group was significantly higher than that of diastolic HF group (P〈0.05). The level was increased with the increase of NYHA class, that is, significantly higher in NYHA class Ⅳ than in NYHA class Ⅲ and in NYHA class Ⅱ (P〈0.05) in every age group. The level was also in a trend of elevation along with aging, though without statistical significance (P〉0.05). Conclusion The median plasma NT-proBNP level is significantly higher in systolic HF than in diastolic HF, and it has a close relationship with NYHA class. NT-proBNP level is not significantly correlated with age.
出处 《中华老年多器官疾病杂志》 2013年第6期447-449,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 N末端B型利钠肽原 收缩性心力衰竭 舒张性心力衰竭 年龄 N-terminal pro-brain natiuretic peptide systolic heart failure diastolic heart failure age
  • 相关文献

参考文献4

  • 1急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:838
  • 2McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2012, 33(14):1787-1847.
  • 3Lubien E, Demeria A, Krishnaswam P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction comparison with Dopplor velocity recordings[J]. Circulation, 2002, 105(5): 595-601.
  • 4Cheitlin MD. Cardiovascular physiology--changes with aging[J]. Am J Geriatr Cardiol, 2003, 12(1): 9-13.

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献837

同被引文献33

  • 1Fonarow G C,Stough W G,Abraham W T,et al.Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry[J].J Am Coll Cardiol,2007,50:768-777.
  • 2Owan T E,Redfield M M.Epidemiology of diastolic heart failure[J].Prog Cardiovasc Dis,2005,47:320-332.
  • 3Lam C,Donal E,Kraigher-krainer E,et al.Epidemiology and clinical course of heart failure with preserved ejection fraction[J].Eur J Heart Fail,2011,13:18-28.
  • 4Januzzi J L,Camargo C A,Anwaruddin S,et al.The N-terminal Pro-BNP investigation of dyspnea in the emergency department(PRIDE)studies[J].Am J Cardiol,2005,95:948-954.
  • 5Januzzi J L,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256patients.The International Collaborative of NT-proBNP Study[J].Eur Heart J,2006,27:330-337.
  • 6Golcuk Y,Golcuk B,Velibey Y,et al.Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure[J].Am J Emerg Med,2013,31:1191-1195.
  • 7Gheorghiade M,Abraham W T,Abert N M,et al.Systolic blood pressure at admission,clinical characteristics,and outcomes in patients hospitalized with acute heart failure[J].JAMA,2006,296:2217-2226.
  • 8Kajimoto K,Sato N,Sakata Y,et al.Relationship between systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes[J].Int J Cardiol,2013,168:4790-4795.
  • 9Basu S.The neglected role of blood pressure in acute heart failure syndrome[J].Heart,2012,98:91-91.
  • 10Mebazaa A,Gayat E,Lassus J,et al.Association between elevated blood glucose and outcome in acute heart failure:results from an international observational cohort[J].J Am Coll Cardiol,2013,61:820-829.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部